Back to search results

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

This study is testing a free software platform called ExerciseRx to help adults with multiple sclerosis (MS) become more physically active. ExerciseRx works with your personal smart devices (like a smartphone) to track your activity and help your healthcare provider suggest tailored exercises. The goal is to see if using ExerciseRx can increase your daily step count over 13 weeks. You might be able to join if you are an adult (18 years or older) with MS, have some ability to walk without assistance, and are not currently getting at least 150 minutes of physical activity each week. The study is planning to enroll 106 participants, but its current status is unclear.

Study design
This is an interventional study planning to enroll 106 participants to test the ExerciseRx intervention.
What's involved
Your physical activity will be measured at the start of the study and again at week 13.
Compensation
Not stated in the trial record.
Follow-up
Your physical activity will be measured at week 13, indicating a follow-up period of at least 13 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06270641

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Recruiting
NAAges 18+InterventionalTreatment
University of Washington
~106 participants
Updated 2024-02-22 on ClinicalTrials.gov
What's tested:ExerciseRx intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Physical activity: daily average step count
Measured over Baseline and week 13

Conditions

Multiple Sclerosis (MS)
Fatigue
Physical Inactivity

Explore related trials

Multiple Sclerosis

Where it's being run

1 sites across 1 states
Washington1

Study leadership

  • Dawn Ehde, PhD · PRINCIPAL_INVESTIGATOR · UW Medicine

Who to contact

Laurie Kavanagh, MPH
[email protected]
206-668-4168
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Provider-confirmed diagnosis of MS using revised 2017 McDonald criteria
\> 18+ years of age
Patient determined disease steps (PDDS) score \< 3, indicating the potential for some gait disability although typically ambulates without an assistive device
Insufficiently active, defined as \< 150 minutes of physical activity per week, assessed using the PAVS in the EHR in clinics as part of the routine patient intake process
Use of an iPhone with software version iOS13+ or an Android phone 4.1+
Agree to install and use the ExerciseRx app for the entire study period and keep their phone on them during the daytime (e.g., pocket, bags, hands)

Exclusion

Recent (past 4 weeks) or planned surgery during the study period which may impact engaging in step counts
MS relapse within the last 30 days
Plans to travel internationally during the study period, which could interfere with server uploads of mobile phone data
Those at a higher risk of falling or injury from falls or unable to safely exercise due to other medical conditions (e.g. heart conditions, diabetes or conditions made worse by walking or physical activity)

What this trial measures

  • Physical activity: daily average step countBaseline and week 13

    Increase in physical activity measured by daily average step count measured by ExerciseRx app. Increase in physical activity will be measured and compared between the ExerciseRx and usual care participants.